Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis

B. Urizar Catalan (Huelva, Spain)

Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Urizar Catalan (Huelva, Spain). Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis. 2034

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Quantitative determination of terbinafine (anti-aspergillar drug ) in human plasma and lung tissue by gas-chromatography and mass spectometry (GC-MS)
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011


Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018




LSC - 2018 - Characterization of decellularized COPD lung matrices using mass spectrometry proteomics
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018

Feasibility study using shotgun sequencing for proteomic analysis of human bronchoalveolar lavage applying HPLC coupled with linear ion trap MS/MS
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005

Contribution of mass spectrometry (SELDI-TOF-MS) to the analysis of low molecular weight proteins in acute and chronic asthma models
Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation
Year: 2008


Metabolomic fingerprinting in the identification of biomarkers in COPD patients
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012


Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


Mass spectrometry proteomic biomarkers identify acute COPD exacerbations
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Metabolic profiling detects biomarkers of protein degradation in COPD patients
Source: Eur Respir J 2012; 40: 345-355
Year: 2012



Comparison of indirect measurements of multiple breath nitrogen washout with mass spectrometry.
Source: International Congress 2019 – Exploring the lungs in various pathophysiological conditions
Year: 2019

The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry
Source: Eur Respir J 2004; 24: Suppl. 48, 213s
Year: 2004

Methodological issues of sample collection and analysis of exhaled breath
Source: Eur Respir Monogr 2010; 49: 96-114
Year: 2010


A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011

Proteonomic fingerprinting of serum for the detection of tuberculosis
Source: Annual Congress 2009 - Novel diagnostics in tuberculosis
Year: 2009


Ion mobility spectrometry in lung transplant patients
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010


Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


The value of rapid speciation of nontuberculous mycobacteria (NTM) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Detection of lung cancer using expired breath analysis by ion mobility spectrometry
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015